Growth-factor gene therapy for neurodegenerative disorders

Area of Science:

• Neuroscience
• Genetics
• Neurological Disorders

Background:

• Preclinical neuroscience has seen significant advancements in the last 20 years.
• Emerging therapies aim to prevent brain cell loss and degeneration, rather than managing symptoms.
• Growth-factor gene therapy is a key area of research for neurological conditions.

Purpose of the Study:

• To review growth-factor gene therapy for Alzheimer's disease, currently in phase I clinical trials.
• To discuss other neurological diseases targeted by gene therapy, including Parkinson's and Huntington's.
• To highlight the transition towards molecular and gene-targeted therapies for neurological diseases.

Main Methods:

• Review of preclinical neuroscience advancements.
• Focus on growth-factor gene therapy as a prospective treatment.
• Discussion of gene therapy applications in various neurological diseases and cancer.
• Analysis of ongoing gene therapy clinical trials.

Main Results:

• Growth-factor gene therapy is a prospective treatment for Alzheimer's disease.
• Gene therapy is being explored for Parkinson's disease, Huntington's disease, inborn errors of metabolism, and cancer.
• Clinical trials are progressing, facilitating the shift to targeted molecular therapies.

Conclusions:

• Gene therapy holds significant potential for preventing neurological cell loss and degeneration.
• The advancement of gene therapy clinical trials is paving the way for improved neurological disease prognoses.
• Molecular and gene-targeted approaches represent a paradigm shift in treating neurological disorders.